Johnson Fistel, LLP investigates potential violations of federal and state laws by certain officers of several publicly traded companies, including DexCom, Inc.
Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback